B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
基本信息
- 批准号:10683443
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-10 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Abnormal CellAccelerationAcuteAddressAffectAffinityAntibodiesAntibody ResponseAntigensAreaAutoimmune DiseasesAutoimmunityB lymphoid malignancyB-Cell ActivationB-Cell Antigen ReceptorB-LymphocytesBasic ScienceCell CompartmentationCell physiologyCellsCellular biologyChronicClinicalClinical ResearchCollaborationsColoradoCommunicable DiseasesDevelopmentDiseaseEducational workshopEnvironmentFosteringGenerationsHIV InfectionsHIV vaccineHealthHumanImmuneImmunityIndividualInflammationInternationalIntrinsic factorKnowledgeLearningMalignant NeoplasmsMature B-LymphocyteMediatorMentorsMethodologyOutcomeParticipantPharmaceutical PreparationsPlayProductivityPublishingResearchResearch PersonnelRoleScienceScientistSignal TransductionVariantantigen-specific T cellscancer cellclinical practiceclinical translationdesignimmunoprophylaxisimprovedknowledge translationmultidisciplinarynext generationpathogenpostersprogramsprospectivepublic health prioritiesrecurrent infectionresponsesymposiumsystemic autoimmunityvaccine development
项目摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled B Cell Biology in the Context of Infectious
Diseases, Autoimmunity and B Cell Cancers, organized by Drs. Susan Pierce and Facundo Batista. The
conference will be held in Keystone, Colorado from June 6 - 10, 2023.
Effective B cell antibody responses are essential for human health and protection against deadly infectious
diseases. However, B cell antibodies are also mediators of devastating autoimmune diseases, and, when
released from normal control mechanisms, B cell malignancies are common; and many remain untreatable. It
is also becoming evident that the mature B cell compartment is highly heterogeneous and that antigen-driven
fates of individual B cells are dependent on several factors, including the affinity of the B cell receptor (BCR)
and how the BCR is wired to the B cell’s activation machinery, along with the quality of the immune
environment as defined by both antigen-specific T cells and innate immune cells responding to pathogen-
derived signals. The generation of long-lived protective immunity versus B cell malignancies, or systemic
autoimmunity, may represent the spectrum of outcomes resulting from variations in and interactions between
these intrinsic factors and the surrounding context. If so, our ability to rationally manipulate B cell responses to
develop vaccines against infectious diseases, as well as therapies for autoimmune diseases and B cell
cancers, may be greatly accelerated by a detailed understanding of the fundamentals of B cell biology. The
translation of this knowledge to clinical and basic research will allow the field to address the most pressing
public health priorities of our times, ranging from acute and chronic infectious diseases to autoimmunity and B
cell malignancies. Finally, this conference is being held jointly with the Keystone Symposia conference, HIV
Vaccines, Immunoprophylaxis and Drugs. This pairing is ideal to discuss how B cell abnormalities contribute
to HIV infection, especially in terms of the potential for antibody-based vaccine development. Participants from
both conferences will have the opportunity to network through shared sessions, mealtimes, and evening poster
sessions.
抽象的
在感染力的背景下,请求支持Keystone研讨会会议,名为B细胞生物学
由DRS组织的疾病,自身免疫性和B细胞癌。 Susan Pierce和Facundo Batista。这
会议将于2023年6月6日至10日在科罗拉多州的基斯通举行。
有效的B细胞抗体反应对于人类健康和防止致命感染至关重要
疾病。但是,B细胞抗体也是毁灭性自身免疫性疾病的介体,当
B细胞恶性肿瘤是从正常控制机制中释放出来的。许多人仍然无法治疗。
也有证据表明成熟的B细胞室是高度异质性的,并且抗原驱动
单个B细胞的命运取决于几个因素,包括B细胞受体的亲和力(BCR)
以及如何将BCR连接到B细胞的激活机械以及免疫的质量
环境由抗原特异性T细胞和先天免疫细胞响应于病原体 -
派生的信号。长期保护的免疫与B细胞恶性肿瘤或全身性生成
自身免疫性可能代表因变化和相互作用而产生的结果的范围
这些内在因素和周围环境。如果是这样,我们合理操纵B细胞反应的能力
开发针对传染病的疫苗以及自身免疫性疾病和B细胞的疗法
对B细胞生物学的基本面的详细理解,癌症可能会大大加快癌症。
将这些知识转换为临床和基础研究将使该领域能够解决最紧迫的问题
我们时代的公共卫生优先事项,从急性和慢性传染病到自身免疫和B
细胞恶性肿瘤。最后,该会议将与Keystone研讨会会议共同举行。
疫苗,免疫预防和药物。这种配对是讨论B细胞异常如何贡献的理想选择
艾滋病毒感染,特别是在基于抗体的疫苗开发的潜力方面。来自
这两个会议都将有机会通过共享的会议,进餐时间和晚间海报进行联网
会议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TERRY L. SHEPPARD其他文献
TERRY L. SHEPPARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TERRY L. SHEPPARD', 18)}}的其他基金
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
肺动脉高压:最新技术和治疗机会
- 批准号:
10682118 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
妊娠期感染:致病机制、实验进展和临床策略
- 批准号:
10540260 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
微生物群-免疫相互作用的机制-迈向下一个十年
- 批准号:
10753451 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
长期新冠肺炎和 SARS CoV 2 (PASC) 急性后遗症:发病机制和治疗
- 批准号:
10749522 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Transposable Elements at the Crossroads of Evolution, Health and Disease
处于进化、健康和疾病十字路口的转座元件
- 批准号:
10750852 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Inflammation in the Lung: Friend or Foe in Viral Infections?
肺部炎症:病毒感染的朋友还是敌人?
- 批准号:
10681956 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
B 细胞和三级淋巴结构:癌症治疗的新兴靶点
- 批准号:
10754008 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
相似国自然基金
基于腔光机械效应的石墨烯光纤加速度计研究
- 批准号:62305039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于自持相干放大的高精度微腔光力加速度计研究
- 批准号:52305621
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
位移、加速度双控式自复位支撑-高层钢框架结构的抗震设计方法及韧性评估研究
- 批准号:52308484
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高离心加速度行星排滚针轴承多场耦合特性与保持架断裂失效机理研究
- 批准号:52305047
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于偏心光纤包层光栅的矢量振动加速度传感技术研究
- 批准号:62305269
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Defining the Pathogenesis of Del(7q) in Hematopoietic Stem Cells
定义造血干细胞中 Del(7q) 的发病机制
- 批准号:
10647633 - 财政年份:2022
- 资助金额:
$ 1.5万 - 项目类别:
Regulation of NK cell antiviral responses through alternative splicing
通过选择性剪接调节 NK 细胞抗病毒反应
- 批准号:
10836667 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Regulation of NK cell antiviral responses through alternative splicing
通过选择性剪接调节 NK 细胞抗病毒反应
- 批准号:
10550262 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Epigenomic Regulation in Pancreatic Cell Growth
胰腺细胞生长的表观基因组调控
- 批准号:
10541852 - 财政年份:1998
- 资助金额:
$ 1.5万 - 项目类别:
Epigenomic Regulation in Pancreatic Cell Growth
胰腺细胞生长的表观基因组调控
- 批准号:
10600724 - 财政年份:1998
- 资助金额:
$ 1.5万 - 项目类别: